Top Private Equity News, Member Posts, Managed Futures Daily Indices and more!

2yrs ago Private Equity privateequitywire Views: 761

Argand Partners' Cherry acquires Active Key

Submitted 11/05/2021 - 8:51am

Cherry, a portfolio company of a New York- and San Francisco Bay Area-based industrials private equity firm Argand Partners has Active Key, a Germany-based leading manufacturer of hygienic, washable keyboards and mice for medical and industrial end-markets.

Active Key is a leading brand in the development and engineering of specialist keyboards and mice that are used in medical, industrial, point-of-sale and office applications. Its product range includes keyboards that are resistant to dust and moisture, fully sealed keyboards that can be easily sanitised, programmable keyboards, and keyboards with integrated card readers. This acquisition strengthens Cherry’s position as a leading provider of healthcare peripherals.  

This transaction represents the second of several strategically valuable bolt-on acquisitions planned for Cherry under Argand’s ownership. Cherry is the world’s leading global designer and manufacturer of high-precision keyboard mechanical switch technology for PC gaming and professional use computing peripheral products. The company designs and manufactures premium key switches for mechanical keyboards, branded gaming peripherals, computer input devices (including mice and keyboards), and products for high-security and point of sale peripheral applications. 

The Active Key acquisition brings significant specialist technical and engineering expertise in-house, expands Cherry’s healthcare product portfolio and meets increased customer demand for hygienic and washable computer peripherals. The current environment is driving rising demand for specialised keyboards and mice in healthcare and other industrial settings. This acquisition adds depth to Cherry’s healthcare offerings and will enable future applications of hygienic and washable technology across Cherry’s broader product portfolio and end-markets. 

Dino Sawaya, Principal at Argand, says: “We are delighted to support this strategic acquisition and welcome Active Key into the Cherry family. A deep product portfolio is increasingly important to serve the healthcare sector, and this acquisition strengthens Cherry’s technological and product development leadership, diversifies Cherry’s product portfolio, and enables future applications of hygienic and washable technology.”    

 

Like this article? Sign up to our free newsletter Tags Deals & Transactions Acquisitions Manufacturing Technology & Software

Today's Private Equity Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.